Linked Life Data

11899827

Source:http://linkedlifedata.com/resource/pubmed/id/11899827

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11899827rdf:typepubmed:Citationlld:pubmed
pubmed-article:11899827lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0020538lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0003009lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0597357lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0005823lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0441767lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0205161lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C1979963lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C1947976lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0205464lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0237881lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C2003903lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0750502lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C0332206lld:lifeskim
pubmed-article:11899827lifeskim:mentionsumls-concept:C2827666lld:lifeskim
pubmed-article:11899827pubmed:issue2lld:pubmed
pubmed-article:11899827pubmed:dateCreated2002-3-19lld:pubmed
pubmed-article:11899827pubmed:abstractTextTo specify variable 24-h arterial hypertension (AH) stage II profile and to assess significance of pharmacological block of the end of the renin-angiotensin-aldosteron system for correction of the determined disorders.lld:pubmed
pubmed-article:11899827pubmed:languageruslld:pubmed
pubmed-article:11899827pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11899827pubmed:citationSubsetIMlld:pubmed
pubmed-article:11899827pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11899827pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11899827pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11899827pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11899827pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11899827pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11899827pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11899827pubmed:statusMEDLINElld:pubmed
pubmed-article:11899827pubmed:issn0040-3660lld:pubmed
pubmed-article:11899827pubmed:authorpubmed-author:ShustovS BSBlld:pubmed
pubmed-article:11899827pubmed:authorpubmed-author:KulikovA NANlld:pubmed
pubmed-article:11899827pubmed:authorpubmed-author:KonevA VAVlld:pubmed
pubmed-article:11899827pubmed:authorpubmed-author:BarsukovA VAVlld:pubmed
pubmed-article:11899827pubmed:authorpubmed-author:Al'-IazidiM...lld:pubmed
pubmed-article:11899827pubmed:issnTypePrintlld:pubmed
pubmed-article:11899827pubmed:volume74lld:pubmed
pubmed-article:11899827pubmed:ownerNLMlld:pubmed
pubmed-article:11899827pubmed:authorsCompleteYlld:pubmed
pubmed-article:11899827pubmed:pagination52-5lld:pubmed
pubmed-article:11899827pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:meshHeadingpubmed-meshheading:11899827...lld:pubmed
pubmed-article:11899827pubmed:year2002lld:pubmed
pubmed-article:11899827pubmed:articleTitle[Significance of pharmacological blockade of angiotensin II type I receptors for correction of abnormal 24-hour blood pressure profile depending on its variability in patients with arterial hypertension stage II].lld:pubmed
pubmed-article:11899827pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11899827pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:11899827pubmed:publicationTypeEnglish Abstractlld:pubmed